Taiwan · Delayed Price · Currency is TWD Tanvex BioPharma Statistics
Total Valuation
TPE:6541 has a market cap or net worth of TWD 7.45 billion. The enterprise value is 9.17 billion.
| Market Cap | 7.45B |
| Enterprise Value | 9.17B |
Important Dates
The next estimated earnings date is Wednesday, November 18, 2026.
| Earnings Date | Nov 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPE:6541 has 264.99 million shares outstanding. The number of shares has increased by 20.60% in one year.
| Current Share Class | 264.99M |
| Shares Outstanding | 264.99M |
| Shares Change (YoY) | +20.60% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 1.15% |
| Owned by Institutions (%) | 3.80% |
| Float | 108.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.78 |
| PB Ratio | 1.63 |
| P/TBV Ratio | 6.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.04 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.63 |
Financial Efficiency
Return on equity (ROE) is -30.11% and return on invested capital (ROIC) is -12.98%.
| Return on Equity (ROE) | -30.11% |
| Return on Assets (ROA) | -11.96% |
| Return on Invested Capital (ROIC) | -12.98% |
| Return on Capital Employed (ROCE) | -23.63% |
| Weighted Average Cost of Capital (WACC) | 4.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.09 |
| Inventory Turnover | 4.71 |
Taxes
| Income Tax | -5.81M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.19% in the last 52 weeks. The beta is 0.23, so TPE:6541's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -49.19% |
| 50-Day Moving Average | 30.53 |
| 200-Day Moving Average | 39.10 |
| Relative Strength Index (RSI) | 41.66 |
| Average Volume (20 Days) | 377,212 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:6541 had revenue of TWD 691.06 million and -1.59 billion in losses. Loss per share was -6.01.
| Revenue | 691.06M |
| Gross Profit | -976.95M |
| Operating Income | -1.50B |
| Pretax Income | -1.60B |
| Net Income | -1.59B |
| EBITDA | -1.36B |
| EBIT | -1.50B |
| Loss Per Share | -6.01 |
Balance Sheet
The company has 602.71 million in cash and 2.33 billion in debt, with a net cash position of -1.73 billion or -6.52 per share.
| Cash & Cash Equivalents | 602.71M |
| Total Debt | 2.33B |
| Net Cash | -1.73B |
| Net Cash Per Share | -6.52 |
| Equity (Book Value) | 4.57B |
| Book Value Per Share | 17.26 |
| Working Capital | 41.43M |
Cash Flow
In the last 12 months, operating cash flow was -970.25 million and capital expenditures -706.84 million, giving a free cash flow of -1.68 billion.
| Operating Cash Flow | -970.25M |
| Capital Expenditures | -706.84M |
| Depreciation & Amortization | 142.03M |
| Net Borrowing | 746.99M |
| Free Cash Flow | -1.68B |
| FCF Per Share | -6.33 |
Margins
Gross margin is -141.37%, with operating and profit margins of -217.14% and -230.36%.
| Gross Margin | -141.37% |
| Operating Margin | -217.14% |
| Pretax Margin | -231.20% |
| Profit Margin | -230.36% |
| EBITDA Margin | -196.59% |
| EBIT Margin | -217.14% |
| FCF Margin | n/a |
Dividends & Yields
TPE:6541 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -20.60% |
| Shareholder Yield | -20.60% |
| Earnings Yield | -21.40% |
| FCF Yield | -22.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on March 2, 2023. It was a reverse split with a ratio of 0.3335779572.
| Last Split Date | Mar 2, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.3335779572 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |